Uncategorized
This week in Drug Discovery (16 – 20 March)

News round-up for 16 – 20 March February by Bruno Quinney, Content Team at DDW.
This week, a pioneering method is being used to make drugs for Parkinson’s disease. Elsewhere, advances have been made in both research and trials for common cancers.
The top stories:
Edinburgh team makes Parkinson’s drug from plastic bottles
A drug to treat Parkinson’s disease can be made from waste plastic bottles using a pioneering method, a study shows.
Read more…
Cancer enzyme discovery opens new avenues for drug discovery
Researchers have identified the enzyme DHX8 as a crucial regulator of the stress response protein HSF1, which may have potential to open new avenues for future drug development.
Research identifies new target for multiple myeloma treatment
New research published in the Clinical Lymphoma, Myeloma & Leukemia journal has confirmed that Kappa Myeloma Antigen (KMA) and Lambda Myeloma Antigen (LMA) are promising therapeutic targets for the treatment of multiple myeloma.
First patient dosed in ROR1-positive blood cancer treatment
The first patient has been dosed with NVG-222, a treatment for ROR1-positive blood cancers developed by biotechnology company NovalGen.
Rare disease drugs to generate $400bn by 2032, report reveals
Evaluate’s ‘2026 Orphan Drug Report’ predicts the sales of orphan drugs will continue to rise steadily, despite policy changes and pricing turmoil. According to the forecast, orphan drugs will account for over 21% of all prescription pharmaceutical drugs by 2032.
Read more…
The post This week in Drug Discovery (16 – 20 March) appeared first on Drug Discovery World (DDW).
Uncategorized
Terns rebuffed a higher bid before selling to Merck

Regulatory filings show that Terns ultimately accepted an offer 15% lower than a previous proposal as four companies vied for rights to the coveted leukemia drug developer.

Regulatory filings show that Terns ultimately accepted an offer 15% lower than a previous proposal as four companies vied for rights to the coveted leukemia drug developer.
Uncategorized
STAT+: States looking to regulate use of chatbots
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.
Good morning health tech readers!
Today, a deep dive into why America’s most powerful health insurer is looking more and more like a technology company.
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.
Good morning health tech readers!
Today, a deep dive into why America’s most powerful health insurer is looking more and more like a technology company.
Uncategorized
ARPA-H selects three teams in $100M effort to repair and regrow ailing joints
Three academic centers believe they may have discovered new ways to heal aging joints. Now the federal government is funding clinical trials to test these experimental regenerative medicines in osteoarthritis.
Teams from Duke University, the …
-
Uncategorized9 years agoThese ’90s fashion trends are making a comeback in 2017
-
Contributors9 years agoThe final 6 ‘Game of Thrones’ episodes might feel like a full season
-
Uncategorized9 years agoAccording to Dior Couture, this taboo fashion accessory is back
-
Uncategorized9 years agoThe old and New Edition cast comes together to perform
-
Uncategorized9 years agoPhillies’ Aaron Altherr makes mind-boggling barehanded play
-
Uncategorized9 years agoUber and Lyft are finally available in all of New York State
-
Uncategorized9 years agoDisney’s live-action Aladdin finally finds its stars
-
Uncategorized9 years agoSteph Curry finally got the contract he deserves from the Warriors